ニコチンアセチルコリン受容体に対するナリゲニンとナリゲニンの分子調節と亜型特異的作用
Jeongyeon Yun1, Myungmi Moon1, Jaehui Yang1
1Department of Biotechnology and Department of Integrative Food, Bioscience and Biotechnology (BK21 FOUR), Chonnam National University, Gwangju 61186, South Korea.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|September 2, 2025
まとめ
シトルスのフラボノイドであるナリンゲニンとナリンゲンは,特定のニコチンアセチルコリン受容体 (nAChRs) を選択的に抑制する. この発見は 自律神経系疾患の標的治療の開発に 可能性を秘めています
科学分野:
- 薬理学について
- 神経科学
- 生物化学
背景:
- ナリゲンニンとナリゲンニンは,神経保護性および抗癌性があると知られている類のフラボノイドです.
- ニコチンアセチルコリン受容体 (nAChR) は神経伝達に不可欠であり,様々な疾患に関与しています.
- これらのフラボノイドとnAChRサブタイプとの特定の相互作用はよく定義されていません.
研究 の 目的:
- ナリゲニンとナリゲニンがヒトの異なるニコチンアセチルコリン受容体サブタイプとの相互作用を調査する.
- nAChR調節剤としてのナリンゲニンとナリンゲニンのメカニズムと選択性を決定する.
主な方法:
- ヒトのnAChRサブタイプを発現するXenopus laevis卵細胞における2つの電極電圧クリップの記録
- nAChRサブユニットのサイト指向型変異.
- 結合部位と相互作用を特定するための分子ドッキングシミュレーション
主要な成果:
- ナルリンゲンとナルリンゲンは,非競争的にα3β2およびα3β4のnAChRサブタイプを,濃度に依存し,可逆的に抑制した.
- 変異分析と分子ドッキングにより,特定のnAChRサブタイプへの選択的結合が確認されました.
- 神経変性に関連したα7およびα4β2のnAChRサブタイプは,これらのフラボノイドによって影響を受けませんでした.
結論:
- ナルリンゲンとナルリンゲンは,特定のnAChRサブタイプ,特に自律神経系の選択的阻害剤として作用する.
- これらの発見は,これらのnAChRサブタイプを含む状態のための標的治療薬としてナルリンゲンとナルリンゲンの潜在的な開発を支持する.
関連する概念動画
Cholinergic Receptors: Nicotinic
3.4K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
3.4K
Cholinergic Receptors: Muscarinic
2.9K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.9K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.2K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.2K
Parasympathetic Signaling
2.1K
Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
The effects of...
2.1K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.4K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.4K
Adrenergic Receptors: β Subtype
2.0K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
2.0K


